NCT05186142

Brief Summary

Tissue Elastography Assessement and Cuteous and Cubcutaneous Thickness Measurement Following Manual Lymph Drainage in Legs With Lymphedema Hence the importance of evaluating the impact of an intensive five-day decongestive treatment on lymphedema in terms of cutaneous flexibility and edema regression. Patients who are undergoing intensive decongestive treatment for four or five days in the department perform an ultrasound check/examiantion on the first day. During this echography, in 5 usual measurement points are made an ultrasound image recording (for measurement of cutaneous and subcutaneous thicknesses) and an elastography sequence (an instantaneous measurement). The study hypothesis is to note that intensive decongestive treatment has an impact on tissues flexibility and cutaneous and subcutaneous thickness. No many authors discussed this suject, hence the interest of this study. All the data collected and the results obtained will serve for further studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2019

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

November 12, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
Last Updated

January 11, 2022

Status Verified

December 1, 2021

Enrollment Period

3 months

First QC Date

November 12, 2021

Last Update Submit

December 22, 2021

Conditions

Keywords

Skin supplenessElastographylymphedemaManual Lymphatic Drainage

Outcome Measures

Primary Outcomes (2)

  • number of Elastography

    number of Elastography

    day 1 (pre treatment)

  • number of Elastography

    number of Elastography

    day 5 (post treatment)

Secondary Outcomes (6)

  • number of Cutaneous thicknesses

    day 1 (pre treatment)

  • number of Cutaneous thicknesses

    day 5 (post treatment)

  • number of Subcutaneous thicknesses

    day 1 (pre treatment)

  • number of Subcutaneous thicknesses

    day 5 (post treatment)

  • number of Limb volumetry

    day 1 (pre treatment)

  • +1 more secondary outcomes

Study Arms (1)

Patients hospitalized for treatment of lymphoedema

Patients hospitalized for treatment of lymphoedema

Other: Ultrasonography / Ultrasound elastography

Interventions

Ultrasonography / Ultrasound elastography

Patients hospitalized for treatment of lymphoedema

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients receinving intensive treatment for lower limb lymphedema at UHC Saint Eloi. Patients with lower limb lymphedema coming to UHC Saint Eloi for intensive treatment.

You may qualify if:

  • Major patients with unilateral or bilateral lymphedema of the lower limb (s), stage II or III, of primary or secondary origin
  • Major patients with admitted for the realization of an Intensive Decongestive Treatment (TDI) of three to five days in the lymphology unit of the Saint Eloi hospital, of Montpellier UHC.

You may not qualify if:

  • Patients with different lymphedema localisation than the lower limbs
  • Patient with amputated
  • patient not consenting or included in another clinical research study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Lymphedema

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Officials

  • MESTRE GODIN Sandrine

    University Hospital, Montpellier

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2021

First Posted

January 11, 2022

Study Start

May 1, 2019

Primary Completion

August 1, 2019

Study Completion

October 20, 2019

Last Updated

January 11, 2022

Record last verified: 2021-12

Locations